[Effect of an inosite-nicotinic acid-ester on serum lipid changes in patients with vascular diseases].
D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D001786:Blood Glucose / Q000032:analysis; D002208:Caproates / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D004952:Esters / Q000627:therapeutic use; D005227:Fatty Acids / Q000097:blood; D006801:Humans; D007294:Inositol / Q000627:therapeutic use; D007773:Lactates / Q000097:blood; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000097:blood; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D011773:Pyruvates / Q000097:blood; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D002208:Caproates; D004952:Esters; D005227:Fatty Acids; D007773:Lactates; D008074:Lipoproteins; D009539:Nicotinic Acids; D011773:Pyruvates; D014280:Triglycerides; D007294:Inositol; D002784:Cholesterol
Einfluss eis Inosit-Nikotinsäureesters Hexanicit forte auf Serumlipidveränderungen bei Gefässkranken.